News

bit.bio Wins Honours for Innovation in Synthetic Biology and Exceptional Business Growth.

bit.bio appoints new Chief Financial Officer, Przemek Obloj

bit.bio launches panel of 16 neurodegenerative disease models for research and drug discovery in Alzheimer’s and Parkinson’s disea...

Presenting our first annual sustainability report, detailing our Corporate Sustainability Strategy and progress towards our aligne...

bit.bio CEO Dr Mark Kotter was interviewed by Jon Chee on the Biotech Startups Podcast.

CEO Mark Kotter, shares insights in an exclusive interview with Genetic Engineering & Biotechnology News about the revolutionary C...

CEO and founder, Mark Kotter, recently joined the ScaleUp Radio podcast!

bit.bio launches ioAstrocytes, advancing how scientists can model the human brain.